Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-07 Sale |
2025-01-10 5:53 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
51,420 | $94.48 | $4,858,119 | 1,720 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-06 6:05 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
18,006 | $78.18 | $1,407,686 | 53,140 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-06 6:04 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
1,430 | $76.04 | $108,737 | 26,770 (Direct) |
View |
| 2024-12-16 Sale |
2024-12-18 6:22 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
10,501 | $76.75 | $805,995 | 239,896 (Direct) |
View |
| 2024-12-16 Sale |
2024-12-18 6:21 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
3,728 | $76.75 | $286,139 | 92,972 (Direct) |
View |
| 2024-12-09 Sale |
2024-12-11 7:19 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
3,661 | $76.37 | $279,598 | 115,269 (Direct) |
View |
| 2024-12-09 Sale |
2024-12-11 7:18 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
1,137 | $76.37 | $86,836 | 44,428 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-03 7:21 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
263 | $78.39 | $20,617 | 28,427 (Direct) |
View |
| 2024-11-21 Sale |
2024-11-25 6:21 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
22,000 | $74.81 | $1,645,810 | 22,951 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-21 8:21 pm |
GeneDx Holdings Corp. | WGS | Ryan Jason Director |
47,000 | $70.57 | $3,316,880 | 141,486 (Indirect Direct) |
View |
| 2024-11-15 Sale |
2024-11-19 8:00 pm |
GeneDx Holdings Corp. | WGS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI MOUNT SINAI HEALTH SYSTEM INC. 10% Owner |
147,141 | $70.64 | $10,393,723 | 2,719,692 (Direct) |
View |
| 2024-11-15 Sale |
2024-11-19 7:05 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
45,415 | $70.41 | $3,197,684 | 60,011 (Direct) |
View |
| 2024-10-31 Sale |
2024-11-04 5:01 pm |
GeneDx Holdings Corp. | WGS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI MOUNT SINAI HEALTH SYSTEM INC. 10% Owner |
865,800 | $75 | $64,935,000 | 2,866,833 (Direct) |
View |
| 2024-10-29 Sale |
2024-10-31 5:14 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
274 | $66.6 | $18,248 | 49,471 (Direct) |
View |
| 2024-10-29 Sale |
2024-10-31 5:13 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
2,154 | $66.6 | $143,456 | 128,670 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-18 4:28 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
10,501 | $37.59 | $394,733 | 291,206 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-18 4:26 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
2,635 | $37.59 | $99,050 | 116,441 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-11 8:14 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
895 | $33.33 | $29,830 | 62,069 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-11 8:10 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
3,639 | $33.33 | $121,288 | 154,376 (Direct) |
View |
| 2024-09-03 Sale |
2024-09-04 8:10 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
262 | $31.71 | $8,308 | 44,082 (Direct) |
View |
| 2024-08-15 Sale |
2024-08-19 5:23 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
139,824 | $34.02 | $4,756,875 | 2,646,972 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 4:50 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
84,774 | $34.19 | $2,898,314 | 2,786,796 (Direct) |
View |
| 2024-08-06 Sale |
2024-08-08 5:39 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
112,994 | $31.54 | $3,563,807 | 2,871,570 (Direct) |
View |
| 2024-07-31 Sale |
2024-08-02 4:21 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
88,839 | $33.5 | $2,976,346 | 2,984,564 (Direct) |
View |
| 2024-07-29 Sale |
2024-07-31 5:03 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
50,000 | $33.86 | $1,692,890 | 3,073,403 (Direct) |
View |
| 2024-07-29 Sale |
2024-07-31 4:40 pm |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
2,154 | $33.54 | $72,245 | 119,668 (Direct) |
View |
| 2024-07-29 Sale |
2024-07-31 4:39 pm |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
274 | $33.54 | $9,190 | 43,161 (Direct) |
View |
| 2024-07-24 Sale |
2024-07-26 7:49 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
135,000 | $33.78 | $4,560,363 | 3,123,403 (Direct) |
View |
| 2024-07-19 Sale |
2024-07-23 5:16 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
150,000 | $32.98 | $4,946,935 | 3,258,403 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 6:46 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
25,000 | $32.93 | $823,188 | 3,408,403 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-09 4:07 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
36,118 | $28.24 | $1,020,016 | 3,433,403 (Direct) |
View |
| 2024-07-01 Sale |
2024-07-03 4:56 pm |
GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner |
89,082 | $27.58 | $2,457,286 | 3,469,521 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-16 Exercise |
2024-12-18 6:22 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
18,750 | $0 | 239,896 (Direct) |
View |
| 2024-12-16 Exercise |
2024-12-18 6:21 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
7,197 | $0 | 92,972 (Direct) |
View |
| 2024-12-09 Exercise |
2024-12-11 7:19 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
6,547 | $0 | 115,269 (Direct) |
View |
| 2024-12-09 Exercise |
2024-12-11 7:18 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
2,462 | $0 | 44,428 (Direct) |
View |
| 2024-12-01 Exercise |
2024-12-03 7:21 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
718 | $0 | 28,427 (Direct) |
View |
| 2024-11-19 Gift |
2024-11-21 8:21 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Ryan Jason Director |
141,356 | $0 | 141,486 (Indirect) |
View |
| 2024-10-29 Exercise |
2024-10-31 5:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
753 | $0 | 49,471 (Direct) |
View |
| 2024-10-29 Exercise |
2024-10-31 5:13 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
3,874 | $0 | 128,670 (Direct) |
View |
| 2024-10-15 Exercise |
2024-10-17 5:47 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Ryan Jason Director |
130 | $0 | 73,744 (Direct) |
View |
| 2024-10-15 Exercise |
2024-10-17 5:41 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | RUCH JOSHUA Director |
130 | $0 | 7,983 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 4:28 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
18,750 | $0 | 291,206 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 4:26 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
7,197 | $0 | 116,441 (Direct) |
View |
| 2024-09-09 Exercise |
2024-09-11 8:14 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
2,462 | $0 | 62,069 (Direct) |
View |
| 2024-09-09 Exercise |
2024-09-11 8:10 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
6,546 | $0 | 154,376 (Direct) |
View |
| 2024-09-01 Exercise |
2024-09-04 8:10 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
717 | $0 | 44,082 (Direct) |
View |
| 2024-08-01 Other |
2024-08-05 5:32 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli Director 10% Owner |
413,655 | $32.25 | 4,276,352 (Direct) |
View |
| 2024-07-29 Exercise |
2024-07-31 4:40 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer |
3,874 | $0 | 119,668 (Direct) |
View |
| 2024-07-29 Exercise |
2024-07-31 4:39 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER |
753 | $0 | 43,161 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:19 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | RUCH JOSHUA Director |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:18 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Leproust Emily M. Director |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:16 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | PFENNIGER RICHARD C JR Director |
12,924 | $0 | 12,924 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 4:15 pm |
N/A N/A |
GeneDx Holdings Corp. | WGS | Ryan Jason Director |
12,924 | $0 | 12,924 (Direct) |
View |